GITR costimulator (4-Antibody/Incyte)

N/A

Report date: 2025/01/26 19:33:32

Base Information

Drug NameGITR costimulator (4-Antibody/Incyte)
Drug Alias NameGITR-targeted antibody program (4-Antibody/Ludwig Institute/Memorial Sloan-Kettering Cancer Center)GITR-targeted antibody program (Agenus/Ludwig Institute/Memorial Sloan-Kettering Cancer Center)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein agonists
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4-Antibody AG
China Registration ClassN/A

Develop Information

Active Companies4-Antibody AGIncyte Corp
Inactive CompaniesMemorial Sloan Kettering Cancer CenterLudwig Institute For Cancer Research
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A